{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:32:24Z","timestamp":1791995544759,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bonr.2026.101919","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:59:52Z","timestamp":1777183192000},"page":"101919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prior treatment, not vitamin D, predicts romosozumab response in 314 osteoporosis patients: A retrospective cohort study"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2849-6577","authenticated-orcid":false,"given":"Ryo","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4651-1366","authenticated-orcid":false,"given":"Ayumi","family":"Ichisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1596-2647","authenticated-orcid":false,"given":"Kenya","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8792-558X","authenticated-orcid":false,"given":"Masakazu","family":"Kogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1188-7026","authenticated-orcid":false,"given":"Akira","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2026.101919_bb0005","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bonr.2026.101919_bb0010","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00774-019-01009-9","article-title":"Eldecalcitol increases bone mineral density in Chinese osteoporotic patients without vitamin D or calcium supplementation","volume":"37","author":"Jiang","year":"2019","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2026.101919_bb0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clnesp.2022.02.002","article-title":"Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis","volume":"48","author":"Kobayakawa","year":"2022","journal-title":"Clin Nutr ESPEN"},{"issue":"4","key":"10.1016\/j.bonr.2026.101919_bb0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.bone.2011.07.011","article-title":"A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures: a randomized, active comparator, double-blind study","volume":"49","author":"Matsumoto","year":"2011","journal-title":"Bone"},{"issue":"1\u20132","key":"10.1016\/j.bonr.2026.101919_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jsbmb.2010.03.035","article-title":"Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism","volume":"121","author":"Matsumoto","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bonr.2026.101919_bb0030","doi-asserted-by":"crossref","first-page":"17021","DOI":"10.1038\/boneres.2017.21","article-title":"Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment","volume":"5","author":"Nakamura","year":"2017","journal-title":"Bone Res"},{"key":"10.1016\/j.bonr.2026.101919_bb0035","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bonr.2026.101919_bb0040","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bonr.2026.101919_bb0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00198-014-2991-z","article-title":"Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis","volume":"26","author":"Sakai","year":"2015","journal-title":"Osteoporos. Int."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T11:29:49Z","timestamp":1782559789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":9,"alternative-id":["S2352187226000239"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101919","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prior treatment, not vitamin D, predicts romosozumab response in 314 osteoporosis patients: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101919"}}